Related Articles
Is chemoradiation effective or harmful for stage VI gastric cancer patients?
Octreotide acetate enables the administration of chemoradiotherapy, including the oral anticancer drug S-1, in gastric cancer patients with malignant gastrointestinal obstruction
A phase II trial of low dose administration of 5-fluorouracil and cisplatin in patients with advanced and recurrent gastric cancer.
Second-line chemotherapy with combined irinotecan and low-dose cisplatin for patients with metastatic gastric carcinoma resistant to 5-fluorouracil
Short‑term outcomes of preoperative chemoradiotherapy with S‑1 for locally advanced rectal cancer